Background Effective management of minor ailments in community pharmacies could reduce the burden on alternative high-cost services (general practices, Emergency Departments). Evidence is needed regarding the appropriateness of management of these conditions in community pharmacies. Objective To explore the appropriateness of minor ailment management in community pharmacies. Setting Prospective, observational study of simulated patient (SP) visits to community pharmacies in Grampian (Scotland) and East Anglia (England). Method Eighteen pharmacies (nine per centre) were recruited within a 25-mile radius of Aberdeen or Norwich. Consultations for four minor ailments were evaluated: back pain; vomiting/diarrhoea; sore throat; and eye discomfort. Each pharmacy received one SP visit per ailment (four visits/pharmacy; 72 visits total). Visits were audio-recorded and SPs completed a data collection form immediately after each visit. Primary Outcome Measure Each SP consultation was assessed for appropriateness against product licence, practice guidelines and study-specific consensus standards developed by a multi-disciplinary consensus panel. Results Evaluable data were available for 68/72 (94.4%) visits. Most (96%) visits resulted in the sale of a product; advice alone was the outcome of three visits. All product sales complied with the product licence, 52 (76%) visits complied with practice guidelines and seven visits achieved a 'basic' standard according to the consensus standard. Conclusion Appropriateness of care varied according to the standard used. Pharmacy-specific quality standards are needed which are realistic and relevant to the pharmacy context and which reflect legal and clinical guidelines to promote the safe and effective management of minor ailments in this setting.
Introduction
Emergency Departments (EDs) and general practices are overwhelmed by demand, due in part to patients presenting with conditions suitable for management by other service providers, including community pharmacists and their teams. [1, 2] Recent estimates suggest that 5% of ED visits and 13% of general practice visits in the UK are for minor ailments that could have been managed in community pharmacies. [3, 4] At the same time, there is evidence from academic [5, 6] and commercial investigations [7] of low-quality management of these consultations in community pharmacies involving suboptimal advice or inappropriate sales. These findings are of concern at a time when there is increasing interest in promoting the advisory role of the community pharmacist in addition to the technical supply function. [8] This study was part of the 2-year MINA research programme, [4] which derived evidence to inform the future delivery of minor ailment services in community pharmacies in the UK.
Aim
The aim of this study was to explore the appropriateness (process and outcome) of minor ailment management in community pharmacies using simulated patients (SPs).
Method Design and setting
A prospective, observational design was used and included community pharmacies in Grampian (Scotland) and East Anglia (England). SP visits tested the management of four minor ailments.
Recruitment of community pharmacies
Eighteen pharmacies were required (nine each from Grampian and East Anglia), to give a wide variation in terms of type (independent, multiple) and location (urban, rural) . All community pharmacies within a 25-mile radius of the main city in each centre (Aberdeen (n = 35), Norwich (n = 30)) were identified from Health Board (Scotland) and local lists and study invitation packs were mailed. Pharmacies were excluded if they had participated in earlier phases of the MINA programme. [4] Interested pharmacies were stratified by type and location and randomly selected to generate the sample. Signed informed consent was sought from the lead pharmacist within each participating pharmacy. Non-pharmacist staff could opt out of participation if preferred.
Scenario development
The four minor ailments that occur with the highest frequency in EDs and general practices [3, 4, 9] were chosen for scenario development; they were back pain, vomiting and diarrhoea, sore throat and eye discomfort. A standardised scenario for each minor ailment (Table 1) was developed for the SP visits by a 28-person multi-disciplinary consensus panel [4] (see later). Each scenario was derived from actual consultations which occurred during an earlier phase of the MINA programme. [9] Simulated patients and consultations
Ten SPs (one per scenario plus one reserve per centre) were recruited from existing SP groups in the Medical Schools at the Universities of Aberdeen and East Anglia. A 4-h training session, informed by previous studies, [10] was delivered at each centre. Training focused on delivering a standardised performance while responding naturally to pharmacy personnel questions. [11] Each SP was trained to perform one scenario and wore a hidden microphone to digitally record their consultations. To minimise the risk of detection and any resulting Hawthorne effect, [12] pharmacy staff were blind to the timing and number of SP visits, as well as the ailments that would be tested. The order of SP visits to pharmacies was randomised. Participating pharmacists and pharmacy assistants wore study badges throughout the study period to ensure that SPs did not consult non-participating staff. SPs distinguished pharmacy staff from pharmacists by uniforms worn and company name badges. Each pharmacy was supplied with reply-paid postcards to complete (date/time/visit details) and return to the research team, if they suspected receiving an SP visit. Participating pharmacies were scheduled to receive one SP visit per minor ailment, i.e. four visits per pharmacy (72 visits in total) over an 8-week period (February-March 2013).
Primary outcome measure
The appropriateness of the content and outcome of each SP visit was assessed against three standards: the summary of product characteristics (SPC) if a product was sold/supplied; clinical guidelines; and a consensus standard (comprising consultation process and outcome) (developed by the multi-disciplinary consensus panel). Manufacturers' SPCs describe medicinal product properties and the conditions for their use. Existing clinical guidelines were identified for the management of the conditions presented in each of the four scenarios. These included guidelines from SIGN (Scottish Intercollegiate Guidelines Network), NICE (National Institute for Health and Clinical Excellence), NHS Inform (a national health information service in Scotland), and the Royal Pharmaceutical Society (Table 2) .
Scenario-specific consensus standards (which included process and outcome) were developed by the multi-disciplinary consensus panel which comprised community pharmacists (n = 8), ED consultants (n = 4), ED nurses (n = 4), GPs (n = 4), practice nurses (n = 4) and lay members (n = 4) from Scotland, England, Northern Ireland and Wales. Panel members operated independently and the process was conducted by email. An outline scenario was developed for each of the four minor ailments which included a list of possible consultation components in terms of content (information gathering/provision), including questions from the aide memoire known as 'WWHAM' [13] (Who is it for?; What are the symptoms?; How long have the symptoms been present?; Any medication tried already?; what Medication used currently?), and likely outcomes (product sale, advice provision). Panel members were asked to add any items that they perceived would be relevant or important to include in a pharmacy consultation for each scenario. The responses were collated and then fed back to panel members who were asked to indicate which components they considered represented 'basic' or 'good' practice standards for the management of the four conditions in a community pharmacy (Table 3) in terms of process and outcome. Consensus was defined as ≥60% agreement between panel members (i.e. ≥17/28) for both 'basic' or 'good' consultation management. Only items where the consensus threshold was met were included in the final standard. When using these standards to assess SP consultations, all components had to be delivered for the consultation to meet the consensus standard for process. [16] Recommend ibuprofen and paracetamol as a first line of treatment for sore throats Vomiting and diarrhoea NHS Inform [17] Keep hydrated. Advocates the use of anti-diarrhoea medication Eye discomfort RPS [18] Indicates 'marginal benefit with chloramphenicol', but does not discourage it's use 
Data collection
There were two components to the data collection; the digital recordings of the consultation (see above) and a data collection form completed after every visit by the SP. This included:
Staff involved (pharmacist/counter staff) Questions asked Outcome of visit (medication/advice supplied) Perceived professionalism of staff involved (5-point scale)
Overall satisfaction with visit (5-point scale) Number of other customers on premises (as a marker of busyness) Duration of the visit (from digital recorder)
Assessment of the management of minor ailments presented during SP visits
Three researchers (JI, JC and JB) independently validated the data from the data collection forms against digital recordings for quality assurance purposes. Each researcher listened to each digital recording and compared their interpretations with the SP data collection forms. There were few discrepancies and consensus was defined as when two out of three researchers were in agreement.
Data management and analysis
All data were entered into SPSS version 20. [14] Independent accuracy checks were performed on 10% of the data. The results are presented as descriptive statistics.
Ethical approval
Ethical approval was granted by the College of Life Sciences and Medicine Ethics Review Board, University of Aberdeen.
Results
Twenty pharmacies (31% (20/65)) consented to participate; 18 were selected (independent (6), small chain (4) and large chain (8)). Pharmacies were located in urban (5) and suburban (7) areas and small towns (6) .
All planned SP visits (n = 72) were completed. Two pharmacies reported 'suspected' SP visits, one of which corresponded to an actual visit; data from this visit were excluded from analysis. Digital data were unavailable for three visits (due to recording problems), so these were also excluded from the analysis. Evaluable data were available for 68/72 (94.4%) visits. Most (96% n = 65) visits resulted in the sale of a product; advice alone was the outcome of three visits. One-third of visits involved interaction with a pharmacist only. Most visits were conducted when the pharmacies had <3 customers and most SPs waited between 1 and 5 min for their consultation. Three visits lasted more than five minutes (Table 4) .
Appropriateness of consultation process and outcome
All product sales (outcome) complied with the product licence, 52 (76%) visits complied with practice guidelines and seven visits achieved a 'basic' standard according to the consensus standard for process (Tables 5 and  6 ). No consultation achieved a 'good' standard of practice for process. In terms of the content of SP consultations, the extent to which WWHAM [15] components were elicited varied substantially across scenarios (Figure 1) .
Back pain (n = 17): In terms of products sold, all the back pain scenario visits resulted in appropriate outcomes when assessed against both the clinical guidelines and consensus panel standard (Table 5) .
Sore throat (n = 17): The SIGN guideline [16] states that there is no good quality evidence for non-prescription throat sprays, lozenges or gargles. No visit complied with the clinical guidelines because they all resulted in the sale of at least one of these products. In contrast, however, all sales complied with the 'basic' consensus standard in terms of outcome, i.e. products sold.
Vomiting and diarrhoea (n = 17): Ten consultations complied with NHS Inform guidelines [17] which advocate the use of an anti-diarrhoeal product. Six SP visits resulted in the sale of anti-nausea or anti-emetic products, the use of which was not supported by the guideline. Only one consultation fulfilled the basic consensus standard for outcome which advocated advice only.
Eye discomfort (n = 17): Eleven consultations resulted in the sale of chloramphenicol products (suggested as having marginal benefit in the RPSGB guideline [18] ). One visit resulted in advice only and was therefore compliant with the 'basic' outcome standard advocated by the consensus panel. Five other consultations resulted in other eye products being sold.
General professionalism and satisfaction
SPs rated the visits highly in terms of the general professionalism of pharmacy staff involved in their consultation (Table 6 ). High levels of satisfaction (very satisfied/satisfied) were also reported. Of the eight visits where the SP was not satisfied, six involved the same SP. 
Discussion Summary
The appropriateness of the SP visits in terms of process and outcome varied according to the standard used. All SP consultations complied with the SPCs. The majority (n = 76%) of visits also complied with clinical guidelines. Few consultations reflected the standards defined by the consensus panel, particularly in terms of information gathering.
Strengths and limitations
Discrepancies have previously been shown to exist between self-reported and actual recorded data, [19] but in this study, the digital recordings provided objective data for analysis. Non-verbal communication is an important component of healthcare consultations, [20] but was not assessed in this study. Duplicate, independent data extraction and assessment reduced the risk of assessor bias.
The inclusion of different types and locations of pharmacies in two countries with different pharmacy service contracts increased the generalisability of the results. Pharmacies self-selected to participate in the study. No data were collected from the non-participants. It is possible that the participating pharmacies may have had higher levels of appropriate practice compared with non-participants and as such, the results may overestimate appropriate practice across all pharmacies. Furthermore, the inclusion of pharmacies within a 25-mile radius of the study centre may not be comparable with national data due to the omission of rural pharmacies. Female customers are higher users of pharmacies than males, therefore, to maximise face validity, most of the SPs in this study were female. However, there is evidence to suggest that patient gender can influence the type of information given by pharmacists during counselling. [21] Pharmacist/ counter assistant gender may also influence communication during consultations [22] , but pharmacy personnel gender was not recorded in this current study.
General discussion
This study clearly demonstrates that the choice of standard impacts substantially on the assessment of appropriateness. To the best of our knowledge, this has not been reported previously and is a novel finding of our study. Some of the clinical guidelines and consensus standards (for outcome) conflicted with the broader SPC indications. It is unclear to what extent the clinical guidelines used in this study are referred to routinely in community pharmacy practice. No condition-specific clinical guidelines were identified that had been developed for use in Table 4 Summary of consultation characteristics (%n (derived from data collection form) Characteristic
Members of staff involved in consultation Table 5 Assessment of SP consultation outcomes against the summary of product characteristics, guidelines and consensus list proposed outcome
Scenario
Appropriateness of outcome compared with:
Consensus list proposed outcome 100 (17) 100 (17) 15.8 (1) 15.8 (1) Summaries of product characteristics 100 (17) 100 (17) 100 (17) 100 (17) NICE Guideline [30] 100 (17) NHS Inform (Scotland) [17] 100 (17) 82.3 (14) 58.8 (10) SIGN guideline (117), April 2010 [16] 0 (0) Royal pharmaceutical society reference guide [18] 64.7 (11) Outcome of Consultation Appropriate outcome 100 (17) 100 (17) community pharmacies; only product-specific guidelines were identified, e.g. chloramphenicol. [18] Our study highlights a need for clinical guidance to be tailored for use by community pharmacists and their teams and which does not conflict with other accepted guidance. The current lack of standardised tools will not only contribute to a lack of consistency between pharmacists and other health care providers, but may lead to variation in clinical practice and appropriateness of care that is so often reported in the wider international literature. [6] In the UK, the General Pharmaceutical Council is developing standards for the sale or supply of Pharmacy medicines, [23] but the content is as yet unspecified and unlikely to be condition-specific.
The multidisciplinary consensus panel generated 'basic' and 'good' standards for this study. Although the panel included eight community pharmacists, the components of some standards could be considered unrealistic for the management of minor ailments in the community pharmacy context. For example, the vomiting and diarrhoea standard included eliciting whether there were any clinical signs of dehydration including 'reduced urine output, tachycardia' which lack face validity in a community pharmacy setting. Other components of the 'good' standard were also problematic. For example, few 'sore eye' scenario consultations included elicitation of whether the SP was using other medication; there are, however, no major drug interactions associated with the topical use of chloramphenicol which calls into question the validity of this component. These examples demonstrate not only the challenge of measuring appropriateness of healthcare management in this setting but also the potential lack of validity of using standard generic guidance, e.g. WWHAM, to assess a range of conditions when all items may not be relevant.
Consultation process
While community pharmacists and staff in this study asked questions (information gathering) and gave advice in the majority of consultations, some items central to safe supply were asked infrequently. For example, while SPs were often asked about current medication, they were rarely asked about co-morbidities. Similarly, information about how to use medicines was commonly provided, but advice about what to do should symptoms continue was rarely given. Consultations that focus on directions for medication use and dose, rather than on side effects and adverse events, were also identified in a review of counselling practices on prescription medicines in community pharmacies. [24] However, the extent and type of communication between SPs and pharmacists in our study was similar to other studies of OTC medicines in the UK. [11, 25, 26] Comparison with existing literature Effective consultations between pharmacy staff and their patients/customers are crucial to ensuring appropriate medication use and desired patient outcomes in terms of increased patient knowledge, adherence and/or decreased medication errors. [6, 27, 28] Hence, training in information gathering and provision (consultation skills) is now a core part of the pharmacy undergraduate and post-qualification training programmes. [29] The relatively recent Medication Related Consultation Framework (MRCF) [30] is promoted by the Royal Pharmaceutical Society in the UK as a tool for pharmacists to develop their consultation skills in general. However, elements of the framework lack face validity in relation to the management of over-thecounter consultations, e.g. confirmation of patient's identify, documentation of full medical history. Furthermore, most consultations for minor ailments or for OTC medicine requests are dealt with by medicine counter assistants for whom there is no organisation currently responsible (in the UK at least) for providing ongoing training (although it is the responsibility of the pharmacist-in-charge to ensure that staff are competent to deliver their tasks). Indeed, in some countries, e.g. Australia, there is no requirement for support staff to have undertaken any training prior to their involvement in selling or recommending medicines (Pers. Commun, L. Seubert, 2014). The need for tighter regulatory control for pharmacy support staff is paramount, as is the provision of effective and ongoing training for these vital members of the pharmacy workforce.
Research implications
Our study highlights the difficulty of measuring the appropriateness of minor ailment management in the community pharmacy setting. Quality standards are needed by which practice can be consistently, fairly and accurately assessed. The effect on practice of applying such standards also needs to be evaluated. Effective training methods are needed to enhance consultation management in general and communication skills in particular, e.g. information gathering. While there has been minimal evaluation of this to date, there is evidence to suggest that communication behaviour can be enhanced by training. [5] 
Conclusion
The management of minor ailments was appropriate when assessed by two of the three standards used. Lower rates of appropriateness were achieved with the more aspirational consensus standards. There is a need for pharmacists and their staff to enhance their consultation skills not only through improved communication performance, but also by expanding their knowledge of health conditions. This would maximise the effectiveness of the management of minor ailments in the community pharmacy setting. We suggest that the development of quality standards for the management of such conditions is one strategy to improve practice and achieve safe and effective patient care. The use of formal standards would also provide pharmacists and their staff the criteria against which they could expect to be assessed.
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